BioAge Labs, Inc. — Director's Dealing 2026

Jan 15, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAge Labs, Inc. (BIOA)
CIK: 0001709941
Period of Report: 2026-01-13

Reporting Person: Fortney Kristen (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-13	Common Stock	S	233107	$18.1163	Disposed	976949	Direct

Footnotes

F1: The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2024.

F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.385 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.